Piper Jaffray has just issued a downgrade on shares of Boston Scientific (NYSE: BSX) following this morning' s $1.725B settlement ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE